La cadena de opciones muestra datos clave de las opciones de acciones de Solid Power a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Solid Power..

Solid Power (NASDAQ:SLDP) Bolsa, Cadena de Opciones

Solid Power

Solid Power Inc is engaged in solid-state battery technology and manufacturing processes. Its core technology is a sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells. Its commercialization plan is to manufacture and sell electrolytes to Tier 1 battery manufacturers and automotive original equipment manufacturers (OEMs) that choose to produce its battery cells.

Advanced Environmental Recycling Technologies

AERT

AILE

CTXR

HONE

HSON

INTZ

KORE

LITM

NATR

PDYN

REKR

SLDP

VINC

WATT

Descubre los mayores ganadores y perdedores en el mercado previo tras movimientos impactantes en acciones clave hoy.

Las acciones de Vincerx Pharma (VINC) suben alrededor del 64%; 20 acciones que se mueven en premercado

EVAX

IDAI

LIDR

LKCO

LUXH

MGIH

MLGO

MRBK

MTRX

NEUP

ONDS

QRHC

RVSN

VIRX

WTBA

Descubre las acciones que lideran los movimientos en la apertura del mercado, incluyendo repuntes destacados y caídas sorprendentes.

Acciones de Evaxion Biotech (EVAX) suben alrededor del 62%; 20 acciones que se mueven en el premercado

Solid Power Inc

Susquehanna analyst Christopher Rolland maintains Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) with a Neutral and raises the price target from $110 to $150.

News

Price Target

Analyst Ratings

SLAB

Susquehanna Maintains Neutral on Silicon Laboratories, Raises Price Target to $150

<a href="https://www.youtube.com/watch?v=tBEuoGSrG40">https://www.youtube.com/watch?v=tBEuoGSrG40</a>
&nbsp;

Macro Economic Events

Economics

Federal Reserve

President Trump On Philippines, Says Fantastic Military Relations; Close To Trade Deal; Washington-Philippines' Marcos Says Will Reaffirm Strong Ties; U.S. Closest Ally; Will Continue To Foster Ties; Don't Mind If Philippines Gets Along With China

Susquehanna analyst Christopher Rolland maintains Qorvo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>) with a Neutral and raises the price target from $75 to $90.

QRVO

Susquehanna Maintains Neutral on Qorvo, Raises Price Target to $90

President Trump On Fed's Powell, Says It Is Affecting Housing; Rates Should Be 3pts Lower, Maybe More

The alternative energy sector continues to face some uncertainties after President Donald Trump signed <a href="https://www.benzinga.com/news/financing/25/07/46215083/how-trumps-big-beautiful-bill-impacts-snap-medicaid-taxes-and-student-loans">the "One Big Beautiful Bill" (OBBB)</a>.
The Treasury Department has yet to review safe harbor guidelines, and there could be "potential changes to timelines, minimum capex, or definitions of beginning/continuing construction," according to JPMorgan.
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587781de5064ed0001730076/mark-strouse">Analyst Mark Strouse</a> named three stocks as his top picks, citing "U.S. manufacturing, diversified end markets, and/or long-term cash flow visibility."
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
<ul class="wp-block-list">
<li>First Solar Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>): Overweight rating and price target of $208. The company is booked through 2026 and partially into 2030, Strouse said. While the 45X manufacturing credits remain unchanged in OBBB, the new restrictions on FEOC (foreign entities of concern) could lift average selling prices, he added. Section 232 tariffs (primarily targeting steel and aluminum imports) and AD/CVD (anti-dumping/countervailing duty) tariffs could boost demand and prices, the analyst stated. He expects bookings activity to resume over the coming quarters.</li>
</ul>
<ul class="wp-block-list">
<li>HA Sustainable Infrastructure Capital Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HASI#NYSE">HASI</a>): Overweight rating and price target of $42. The company has exposure to diversified end markets, with stable project spreads despite higher cost of capital, Strouse said. He considers HA Sustainable Infrastructure Capital's three-year financial targets as conservative, given the credit rating upgrade in mid-2024.</li>
</ul>
<ul class="wp-block-list">
<li>Brookfield Renewable Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEPC#NYSE">BEPC</a>) and Brookfield Renewable Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEP#NYSE">BEP</a>): BEPC has a price target of $38 and BEP has a price target of $29. Brookfield Renewable's "scale and diversification provide relative safe haven," the analyst stated. The company has enough liquidity to acquire "quality businesses and platforms that lack access to growth capital," he further wrote.</li>
</ul>
Price Action: At the time of publication on Tuesday:
<ul class="wp-block-list">
<li>Shares of First Solar haddeclined by 0.39% to $177.64.</li>
<li>HA Sustainable Infrastructure Capital's stock had climbed 3.44% to $27.64.</li>
<li>Brookfield Renewable's shares had risen by 0.47% to $36.24.</li>
<li>Brookfield Renewable Partners LP had risen by 0.55% to $27.46.</li>
</ul>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46117348/meta-secures-more-clean-energy-for-power-hungry-ai-and-data-center-growth">Meta Secures More Clean Energy For Power Hungry AI And Data Center Growth</a></li>
</ul>
Image: Shutterstock

Analyst Color

BEPC

FSLR

Hannon Armstrong Sustainable Infrastructure Capital

HASI

JPMorgan Picks 3 Top Stocks In Alternative Energy On Heels Of Trump's 'Big Beautiful Bill'

Roper Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROP#NASDAQ">ROP</a>) reported upbeat second-quarter <a href="https://www.benzinga.com/quote/ROP/earnings">results on Monday</a>.
It clocked quarterly adjusted earnings per share of $4.87, beating the street view of $4.83. Quarterly sales of $1.94 billion outpaced the analyst consensus estimate of $1.92 billion.
Roper Technologies expects fiscal 2025 adjusted earnings per share of $19.90-$20.05 (up from the prior $19.80-$20.05), versus the $19.92 analyst consensus estimates. It also raised its full-year total revenue growth outlook to ~13% or $7.95 billion (compared to a previous outlook of ~12% or $7.88 billion and an analyst consensus estimate of $7.86 billion). It reiterated organic revenue growth of +6-7%.
The company anticipates adjusted EPS of $5.08-$5.12 for the third quarter, compared to the $5.08 analyst consensus estimate.
&#8220;We delivered another strong quarter, highlighted by 13% total revenue growth, 7% organic revenue growth, and 10% free cash flow growth,&#8221; said Neil Hunn, Roper Technologies&#8217; President and CEO. &#8220;Our businesses continued to execute at a high level, while further innovating and investing to drive durable, long-term growth. We are particularly excited about how AI capabilities are enhancing our solutions and creating new opportunities, broadly, across our portfolio. Our second quarter growth was balanced across all three segments, as expected, and positions us well for a strong second half.&#8221;
Roper Technologies shares gained 0.6% to trade at $97.60 on Tuesday.
These analysts made changes to their price targets on Roper Technologies following earnings announcement.
<ul class="wp-block-list">
<li>RBC Capital analyst Deane Dray maintained Roper Technologies with an Outperform and raised the price target from $695 to $703.</li>
<li>Truist Securities analyst Terry Tillman maintained the stock with a Buy and raised the price target from $675 to $685.</li>
</ul>
Considering buying ROP stock? Here&#8217;s what analysts think:
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="558" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/22114421/image-312-1024x558.png" alt="" class="wp-image-995757" style="width:670px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/22114421/image-312-1024x558.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/22114421/image-312-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/22114421/image-312-768x419.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/22114421/image-312.png 1097w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/07/46542083/jim-cramer-coffee-chain-general-mills">Jim Cramer: This Coffee Chain Is &#8216;The Way To Go&#8217; But General Mills? &#8216;That&#8217;s A Tough One&#8217;</a></li>
</ul>
Photo via Shutterstock

Earnings

Markets

Trading Ideas

These Analysts Increase Their Forecasts On Roper Technologies After Strong Q2 Results

Susquehanna analyst Christopher Rolland maintains Impinj (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) with a Positive and raises the price target from $130 to $140.

Susquehanna Maintains Positive on Impinj, Raises Price Target to $140

Susquehanna analyst Christopher Rolland maintains ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) with a Positive and raises the price target from $50 to $75.

Susquehanna Maintains Positive on ON Semiconductor, Raises Price Target to $75

Americans trying to get answers about their <a href="https://www.benzinga.com/personal-finance/management/25/06/46056038/still-working-at-69-eligible-for-social-security-should-he-keep-waiting-or-claim-now">Social Security benefits</a> may soon face longer lines at their local office — and it's raising concern in Washington.
In a <a href="https://www.warren.senate.gov/imo/media/doc/letter_to_bisignano_re_reassigning_workers_to_1-800_numbers1.pdf">letter</a> to Social Security Commissioner Frank Bisignano, Sens. Ron Wyden (D-OR) and Elizabeth Warren (D-MA) criticized the agency's recent decision to reassign field office staff to a phone program designed to shorten hold times on the agency's national 1-800 number.
<h2 class="wp-block-heading">‘Robbing Peter to Pay Paul'?</h2>
The move is part of a pilot program that adds thousands of workers to the Social Security Administration's phone system. But those workers are being pulled from field offices — locations where many Americans, especially seniors, go for in-person help with retirement, disability, and other Social Security issues.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/mode-mobile-accredited-investor-offer">Accredited investors can claim pre-IPO shares of Mode Mobile for just $0.30</a>—with up to 120% bonus shares—before this Uber-style disruption hits the public markets</li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
The senators called this approach "a terrible tradeoff," saying it could fix one customer service problem while worsening another. "In a best-case scenario, your efforts to address the 1-800 wait times — even if they are successful — will almost certainly result in a terrible tradeoff, with longer wait times for in-person services, ‘robbing Peter to pay Paul,'" they wrote.&nbsp;
Jessica LaPointe, president of the union representing SSA field office workers, echoed that concern. She told the <a href="https://www.washingtonpost.com/politics/2025/07/10/social-security-phone-service-wait-times/">Washington Post</a> that moving employees from in-person roles to phone duty will create an even larger <a href="https://www.benzinga.com/personal-finance/25/05/45606410/social-security-faces-blowback-as-fraud-detection-flags-just-2-claims-while-retirement-backlog-nears-600000">pile up</a>.&nbsp;
"It's just going to create a vicious cycle of work not getting cleared, people calling for status on work that's sitting because the claims specialists now are going to have to pick up the slack of the customer service representatives that are redeployed to the tele-service centers," she said.
Trending: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a>
<h2 class="wp-block-heading">Long Waits, Staffing Cuts, and a Pilot Program</h2>
The Social Security Administration has faced ongoing criticism over its customer service delays, especially with phone wait times. A <a href="https://www.warren.senate.gov/imo/media/doc/warren_letter_to_bisignano_on_call_wait_times.pdf">recent investigation</a> led by Senator Warren found that callers to SSA's main number sometimes waited nearly two hours, despite official reports claiming much shorter wait times.
The agency launched the pilot program to reduce phone delays by reassigning employees — often with just a few days' notice. According to the senators' letter, these reassignments increased staffing at the 1-800 number by 25%, but left field offices short-handed. In some cases, back-office workers who normally process claims have had to step into public-facing roles.
The senators also questioned the agency's "call-sharing" policy, which automatically reroutes unanswered calls to other offices in the same state. That system can create confusion when agents receiving the call are unfamiliar with a specific case.
See Also: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a>
<h2 class="wp-block-heading">A Broader Pattern?</h2>
Wyden's and <a href="https://www.benzinga.com/news/25/07/46433450/elizabeth-warren-says-convicted-felon-leveraged-trump-familys-crypto-interests-for-pardon-senator-ma">Warren</a>'s letter ties the SSA's current struggles to decisions made during the Trump administration, which they say cut staffing, closed offices, and made the program harder to navigate. They accuse Bisignano of continuing those policies and failing to reverse course.
Now, they're demanding more transparency. Their letter includes detailed questions about how the phone pilot program was planned, its impact on both phone and in-person wait times, and whether more staffing cuts are expected in the future.
<h2 class="wp-block-heading">What It Means for You</h2>
If you rely on Social Security benefits and prefer to visit an office in person, you may experience longer waits in the coming months. While efforts are being made to improve service on the phone, these senators say those improvements may come at a cost.
Wyden and Warren have requested answers from <a href="https://www.benzinga.com/personal-finance/management/25/07/46260419/social-security-trust-fund-remains-a-top-priority-for-the-trump-administration-assures-commissioner-bisignano-experts-arent-so-sure">Bisignano</a> and are urging the SSA to prioritize better staffing across the board, so beneficiaries don't have to choose between help on the phone or help in person.
Read Next: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
Image: Shutterstock

Personal Finance

'A Terrible Tradeoff': Senators Say Fixing SSA Phone Waits Is Gutting In-Person Help

Politics

General

President Trump On Fed's Powell, Says Powell Will Be Out Soon; Economy Is Strong; Keeps Rates Too High; Should Be At 1%; Should Stay In Their Lane

Susquehanna analyst Christopher Rolland maintains MaxLinear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NASDAQ">MXL</a>) with a Neutral and raises the price target from $11 to $15.

Susquehanna Maintains Neutral on MaxLinear, Raises Price Target to $15

Arch Capital Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACGL#NASDAQ">ACGL</a>) has outperformed the market over the past 15 years by 4.62% on an annualized basis producing an average annual return of 16.88%. Currently, Arch Capital Group has a market capitalization of $33.31 billion. 
Buying $100 In ACGL: If an investor had bought $100 of ACGL stock 15 years ago, it would be worth $1,030.41 today based on a price of $88.89 for ACGL at the time of writing.
<h3>Arch Capital Group's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1753199113_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACGL

Here's How Much $100 Invested In Arch Capital Group 15 Years Ago Would Be Worth Today

Susquehanna analyst Christopher Rolland maintains Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) with a Positive and raises the price target from $60 to $90.

MCHP

Susquehanna Maintains Positive on Microchip Technology, Raises Price Target to $90

Susquehanna analyst Christopher Rolland maintains Lumentum Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) with a Positive and raises the price target from $95 to $125.

LITE

Susquehanna Maintains Positive on Lumentum Holdings, Raises Price Target to $125

Here is what they are not talking about on CNBC right now.
The instant experts of the Internet have no interest in the topic as it does not fit their current narrative.
European stocks remain cheap on both an absolute basis and when compared to the United States.
The European economy is not recovering as fast as the United States but is recovering.
In its mid-year outlook analysts at Goldman Sachs (Ticker: GS) suggested that given all the trade turmoil European investors have taken their ball and gone home. The nalsyst noted that " The trend of investors, particularly European investors, reallocating their assets towards Europe is partly being driven by concerns surrounding high US valuations, market concentration, and doubts about continued US economic exceptionalism. This has been reflected in increased fund flows into European stocks year-to-date,&nbsp;coupled with the relatively strong performance of European stock markets."
It is not an inconsiderable sum that Eurozone investors have to spend.
JP Morgan reported in their recent outlook piece that "The backdrop for the European consumer is also improving. Real wages continue to rise, labor markets broadly remain firm, and falling interest rates might finally encourage the region to deploy some of the sizeable savings that were accumulated during the Covid pandemic."
When asked for his view on European stocks Morningstar Analyst Michael Fields said " So overall I would say it's pretty mixed but tilting towards positive, Christopher. On the one hand, you have markets in Europe hitting all-time highs at the moment, which is a bullish sign for markets generally. But also there's the question of where valuations are behind that. Thankfully, we still see some upside to European markets. We think equities in Europe are trading at around a 5% discount, slightly more in the UK. So at least that gives us some headroom to grow in the second half, if indeed the outlook is positive, if the earnings season comes through for Europe as well. There is still a little bit of room for growth, which is good to hear."
As you can clearly see I have not been just attempting to amuse myself when I have been banging on&nbsp; the table and yelling at you to buy European stocks for the past year or so.
Here are three high quality Europen stocks with pristine fundamentals that should be leaders of the next leg higher:
ABB Ltd (Ticker: ABBNY): Electrification, Automation, and a Robotics Spin-Off on the Horizon ABB Ltd. is a Swiss–Swedish multinational industrial technology company with roots going back more than 130 years. The business is focused on four core divisions: Electrification, Motion, Process Automation, and Robotics &amp; Discrete Automation. These are not glamorous sectors, but they are absolutely critical to modern infrastructure, manufacturing, and energy transition.
The Electrification segment provides products and systems for everything from low- and medium-voltage distribution to electric vehicle charging infrastructure and smart building solutions. Motion includes electric motors and drives, while Process Automation delivers control systems, analytics, and field instrumentation to industries like oil and gas, mining, and chemicals. The Robotics division—soon to be spun off—sells industrial and collaborative robots that work alongside humans in factories worldwide.
ABB operates in more than 100 countries with over 100,000 employees. It generated over $32 billion in revenue in 2024. Recent earnings have shown strong order intake and organic growth in the high single digits. The company is benefiting from long-cycle investments in electrification and grid upgrades, particularly in Europe and Asia. It has also taken steps to improve margins through divestitures and automation-led efficiencies.
The upcoming spin-off of its robotics division is a value-unlocking move. Robotics accounted for roughly $4 billion in revenue last year and has strong demand from automotive, electronics, and logistics customers. ABB is one of the few firms globally with a full-stack offering across robotics hardware and software, and the market is finally starting to appreciate that. The spin-off could attract a different investor base and make ABB's remaining operations more focused and capital-efficient.
Zurich Insurance Group (Ticker: ZURVY): A Conservatively Run, Global Underwriting Powerhouse Zurich Insurance is the kind of stock you buy for peace of mind and income. It is Switzerland's largest insurer and one of the most respected names in global insurance, with a history stretching back to 1872. The company operates in more than 200 countries and territories, with a diversified portfolio that includes property and casualty (P&amp;C), life insurance, and reinsurance.
The P&amp;C division provides everything from home and auto insurance for individuals to large-scale commercial and specialty risk products for corporate clients. The life insurance unit offers term and whole life, annuities, and savings products across Europe, Asia, and Latin America. Through its Farmers Group subsidiary in the U.S., Zurich earns steady fee income while Farmers Insurance handles underwriting. This structure gives Zurich stable cash flows without the same underwriting risk burden.
Zurich has earned a reputation for underwriting discipline and conservative reserve practices. Its combined ratio in the P&amp;C business—an indicator of underwriting profitability—has remained below 95%, even during volatile periods. That means Zurich is not only earning on its investment portfolio, but it is also turning a profit on its core insurance operations.
Financially, the company generated nearly $6 billion in net income last year on more than $68 billion in gross premiums and policy fees. Return on equity has consistently been above 20%, and the balance sheet is rock solid, with a Solvency II ratio of over 200%. It has increased its dividend in Swiss francs for several years in a row, and the current yield is in the 4% to 5% range.
Zurich trades at around 17 times earnings and only a fraction of book value—less than 0.2x—which is almost unheard of for a company with this kind of track record. That reflects some investor caution around catastrophe risk and global insurance cycles, but for those willing to look through the noise, it is a bargain. This is a core holding for anyone building a defensive income portfolio.
Haleon plc (Ticker: HLN): The Medicine Cabinet You Own a Piece Of Haleon is a pure-play consumer health business that was spun off from GlaxoSmithKline in mid-2022. It was formed by combining GSK's consumer health business with Pfizer's minority stake. Today, Haleon is the world's largest standalone consumer health company by revenue.
The company owns many of the most recognized and trusted over-the-counter brands globally: Sensodyne (oral care), Voltaren (topical pain relief), Centrum (multivitamins), Advil (pain), Panadol, Flonase (allergy), Theraflu (cold/flu), and Polident (denture care). These brands generate strong repeat sales, carry high margins, and are sold in over 170 markets worldwide.
Haleon's business model is built on brand strength, consumer trust, and distribution scale. It is not chasing high growth, but it is a cash machine. In 2024, the company produced over £11 billion in revenue and more than £2.3 billion in operating cash flow. Operating margins are in the 20% range, and management is targeting expansion through cost efficiencies and product innovation. While the company carries debt from the spin-off transaction, it is reducing leverage steadily and maintaining a manageable payout ratio.
What I like about Haleon is that it combines defensive characteristics—recurring demand, recession-resistant products, and a global footprint—with the potential for margin expansion and steady free cash flow growth. It is not flashy, but it is reliable. The dividend yield is currently around 1.8%, with plenty of room to grow. The company recently bought a minority stake in Tianjin Zhongjin Pharma in China, a move that could help unlock growth in Asia over the next five years.
Litigation related to the old Zantac product remains a headline risk, but the financial impact has been limited so far, and the market appears to be discounting the worst-case scenario already. With Pfizer having exited its stake and institutional support building, Haleon is finding its footing as a standalone public company. I expect further dividend increases and multiple expansion as debt comes down and earnings grow.
This trio of European companies offers a powerful mix of innovation, consistency, and shareholder return. ABB gives you long-term exposure to electrification and automation, with a hidden gem in its robotics business. Zurich is the steady compounder in global insurance, trading at a deep discount despite world-class fundamentals. Haleon is the definition of a consumer health cash cow with upside from debt reduction and margin gains.
Europe is set oft a continued rally into the second half of 2025 and well into next year. These stocks should help you cash in on the trend.

Opinion

ABBNY

ZURVY

Under the Radar: Hidden Value Across the Atlantic – 3 Stocks to Watch

Susquehanna analyst Christopher Rolland maintains Credo Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) with a Positive and raises the price target from $90 to $115.

CRDO

Susquehanna Maintains Positive on Credo Technology Group, Raises Price Target to $115

Halliburton Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) shares traded lower Tuesday despite reporting <a href="https://www.benzinga.com/pressreleases/25/07/b46539439/halliburton-announces-second-quarter-2025-results" target="_blank" rel="noreferrer noopener">second-quarter 2025</a> results that topped revenue estimates and met earnings expectations. The decline followed cautious remarks from CEO Jeff Miller, who warned of a softer-than-expected near-term oilfield services market.
The company reported adjusted earnings of 55 cents per diluted share, which aligns with analyst forecasts. Revenue totaled $5.51 billion, slightly above the $5.42 billion consensus estimate.
Operating income rose to $727 million from $431 million in the prior quarter. Operating margin improved to 13%, compared with about 8% in the previous period. Free cash flow was approximately $582 million, and cash flow from operations totaled $896 million.
Also Read: <a href="https://www.benzinga.com/markets/earnings/25/07/46492669/slb-trims-2025-capital-spending-prioritizing-efficiency-post-championx-deal" target="_blank" rel="noreferrer noopener">SLB Trims 2025 Capital Spending, Prioritizing Efficiency Post-ChampionX Deal</a>
&#8220;We are more differentiated, more collaborative, and better positioned than ever before,&#8221; said CEO Jeff Miller. However, he warned that &#8220;the oilfield services market will be softer than I previously expected over the short to medium term.&#8221;
Miller added that activity reductions in a few large international markets may overshadow strength in other geographies, but reaffirmed the company&#8217;s long-term strategy around growth engines such as drilling, unconventionals, artificial lift, and production services.
<h2 class="wp-block-heading">Segment Performance</h2>
<ul class="wp-block-list">
<li>Completion and Production revenue rose 2% sequentially to $3.2 billion, while operating income dipped 3% to $513 million. Revenue was lifted by strong pressure pumping and completion tool sales in the Western Hemisphere but pressured by lower pricing for stimulation services in U.S. Land.</li>
<li>Drilling and Evaluation revenue also increased 2% to $2.3 billion, but operating income fell 11% to $312 million due to seasonal declines in software sales and higher mobilization costs across product lines.</li>
</ul>
<h2 class="wp-block-heading">Regional Breakdown</h2>
<ul class="wp-block-list">
<li>North America revenue remained flat at $2.3 billion, supported by gains in Canada and U.S. cementing, offset by weaker activity in artificial lift and wireline services in the Gulf of America.</li>
<li>International revenue rose 2% sequentially to $3.3 billion: 
<ul class="wp-block-list">
<li>Latin America: Up 9% to $977 million, driven by higher activity in Mexico, Brazil, and Argentina.</li>
<li>Europe/Africa: Up 6% to $820 million, driven by stronger operations in Norway.</li>
<li>Middle East/Asia: Down 4% to $1.5 billion, mainly due to lower activity in Saudi Arabia and Kuwait.</li>
</ul>
</li>
</ul>
During the quarter, Halliburton repurchased $250 million in common stock, paid a dividend of 17 cents per share, and invested $32 million in its SAP S4 system migration.
During the company&#8217;s earnings conference call, Miller elaborated on the challenges ahead, noting that North America customers are now planning &#8220;meaningful schedule gaps&#8221; in the second half of 2025. He anticipates North America revenue in the second half to decline due to lower drilling and completion activity, leading to an expected full-year North America revenue decline in the low double digits year-over-year. The company continues to observe reductions in activity and lower discretionary spending in response to lower commodity price environments.
Internationally, Halliburton expects full-year revenue to contract by mid-single digits, year-on-year, primarily driven by activity reductions in Saudi Arabia and Mexico. The company also highlighted that tariffs impacted its business by $27 million in the second quarter and anticipates a third-quarter impact of approximately $35 million, or 4 cents per share.
In response to these headwinds, Halliburton plans to reduce costs and retire, stack, or reallocate underperforming assets. Looking ahead to the fourth quarter, the company anticipates Completion and Production (C&amp;P) revenue to reduce and margins to soften, while Drilling and Evaluation (D&amp;E) revenue is expected to increase.
Price Action: HAL shares traded lower by 0.31% to $21.25 at last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/07/46546336/missile-wins-cant-offset-margin-collapse-lockheed-martin-tumbles-after-q2-report" target="_blank" rel="noreferrer noopener">Missile Wins Can&#8217;t Offset Margin Collapse, Lockheed Martin Tumbles After Q2 Report</a></li>
</ul>
Photo by Casimiro PT via Shutterstock

Halliburton CEO's Sobering Outlook Overshadows Q2 Performance

Apple's AAPL.O changes to its App Store rules and fees will likely secure the green light from EU antitrust regulators, people with direct knowledge of the matter said, a move that would stave off potentially hefty daily fines for the iPhone maker.
The company last month said developers will pay a 20% processing fee for purchases made via the App Store, though the fees could go as low as 13% for Apple's small-business program.
Developers who send customers outside the App Store for payment will pay a fee between 5% and 15%. They will also be able to use as many links as they wish to send users to outside forms of payment.
Apple made the changes after the EU antitrust enforcer handed it a 500 million euro ($586.7 million) fine in April and gave it 60 days to comply with the Digital Markets Act aimed at reining in Big Tech and giving rivals more room to compete.
The European Commission is expected to approve the changes in the coming weeks, although the timing could still change, the people said.
"All options remain on the table. We are still assessing Apple's proposed changes," the EU watchdog said.
Apple did not immediately respond to a request for comment. The company earlier this month said it had implemented the changes to avoid punitive daily fines, while criticising the Commission for mandating how it runs its store.
The company could have been hit with daily fines of 5% of its average daily worldwide revenue, or about 50 million euros per day.

Legal

Global

AAPL

'Apple Likely To Gain EU Antitrust Approval For App Store Fees, Rules; EU Approval Of App Store Changes Will Help Apple Stave Off Daily Fines; EU Decision Expected In Coming Weeks, Timing May Still Change, Sources Say' - Reuters Exclusive

Susquehanna analyst Mehdi Hosseini maintains Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) with a Positive and raises the price target from $100 to $120.

COHR

Susquehanna Maintains Positive on Coherent, Raises Price Target to $120

<a href="https://www.bloomberg.com/news/articles/2025-07-22/sarepta-pulls-elevidys-shipment-after-fda-battle-over-duchenne-drug?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-07-22/sarepta-pulls-elevidys-shipment-after-fda-battle-over-duchenne-drug?embedded-checkout=true</a>

SRPT

'Sarepta's Duchenne Therapy Sparked Fears Even Before FDA's Order'- Bloomberg

Press Releases

Solid Power Reports Second Quarter 2024 Results

Financing

Solid Power Selected by U.S. Department of Energy for Up to $50 Million Award Negotiation for Continuous Production of Sulfide-based Solid Electrolyte Materials for Advanced All-Solid-State Batteries

Solid Power, Inc. Announces Timing of Third Quarter 2024 Earnings Release and Conference Call

Solid Power Reports Third Quarter 2024 Results

How Battery Cell Technology is Playing an Extremely Vital Role in Space Exploration

Solid Power Announces Upcoming Investor Conference Participation

Solid Power, Inc. Announces Timing of Full Year 2024 Earnings Release and Conference Call

Solid Power Reports Full Year 2024 Results

Solid Power, Inc. Announces Timing of First Quarter 2025 Earnings Release and Conference Call

Solid Power Reports First Quarter 2025 Results

KULR

LUNR

RKLB

SLDPW

Adient

Autoliv

American Axle & Manufacturing Holdings, Inc. Common Stock

American Axle & Mfg Hldgs

BorgWarner

Cooper-Standard Holdings Inc. Common Stock

Cooper-Standard Holdings

Dana

Dorman Products

ECARX Holdings Inc. - Class A Ordinary shares

ECARX Holdings

Fox Factory Holding

Gentex

Garrett Motion

Holley

Hesai Group - American Depositary Share, each ADS represents one Class B ordinary share

Comments

Solid Power

Solid Power (SLDP) Opciones

Solid Power (NASDAQ:SLDP) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL